외환/환율
📉 부정적
Nurix Therapeutics, Inc. (NRIX) reports Q2 loss, lags revenue estimates
요약
Nurix Therapeutics, Inc. (NRIX) came out with a quarterly loss of $0.81 per share versus the Zacks Consensus Estimate of a loss of $0.73. This compares to a loss of $0.52 per share a year ago. These figures are adjusted for non-recurring items.